Immatics Events Q1 2019

| News

Immatics, a leading company in the field of cancer immunotherapy, will be attending the industry conferences and meetings listed below. You can also download the complete list here: Immatics Events Q1 2019. 

To arrange meetings with Immatics at any of the events, please contact


JP Morgan

January 7th-10th, San Francisco, USA


18th Annual PepTalk: The Protein Science Week

January 14th-18th, San Diego, USA


LSX World Congress

February 5th-6th, London, UK


Cell Gene Therapy Innovation Summit 2019

February 6th-7th, Berlin, Germany


Engineered Immune Cells in Cancer Immunotherapy: From Discovery to Off-the shelf Development

February 15th-16th, Doha, Qatar


CAR-TCR Summit Europe

February 26th-28th, London, UK


Antibody & Protein Therapeutics Asia

February 26th-28th, Tokyo, Japan


Cancer Immunotherapy: Mechanistic Insights to Improve Clinical Benefit

March 10th-14th, Whistler, Canada


26th International Molecular Med TRI-CON

March 10th-15th, San Francisco, USA


Cancer Immunotherapy: Executive Summit Emerging Immuno-Oncology Targets, Modalities, and Combinations

March 11th-13th, San Francisco, USA


BioProcess International US West

March 11th-14th, Santa Clara, USA


Cambridge Healthtech Institute’s 2nd Annual Adoptive Cell-Based Cancer Immunotherapy

March 14th-15th, San Francisco, USA


Bioprocessing Summit Europe

March 19th-21st, Lisbon, Portugal


BioEurope Spring

March 25th-27th, Vienna, Austria


AACR Annual Meeting 2019

March 29th – April 3rd, Atlanta, USA


Press Contact

Anja Heuer

Corporate Communications,
Immatics Biotechnologies GmbH

+49 89 540 415 606

Go back

We use cookies to ensure that we give you the best experience on our website.